InvestorsHub Logo
Followers 1
Posts 330
Boards Moderated 0
Alias Born 09/26/2012

Re: johnsyn post# 12145

Friday, 12/21/2012 11:41:54 AM

Friday, December 21, 2012 11:41:54 AM

Post# of 58919
Its a shame you missed 90% of it johnsyn i hope you get a transcript because at the moment it Sounds like I am the only one here to take some comfort from the CC.

For me the biggest thing the Dr said re revenues was that last month they completed the assignment with the DLA and they passed every test. I understand this to mean they can only at that point charge up to $960,000. If you add that to our new Swedish business and comparable turnover for the same period it looks as though APDN could achieve sales of over $1.5 mill in the current quarter. Very close to break even without adding any new mandate work.

The Dr did say that the reported growth of 91% was just a foundation a platform, but it wasn't good enough hence the additional staff and floor space.

I agree we are left reading between the lines somewhat but I guess that's how the company operate. Even today's PR "thousands" of DNA marking kits with full traceability. Each pack has got to be $20 just 10,000 packs in London = $200,000 in one sale. What I am trying to say is the good Dr was very bullish on the outlook of APDN.

He said "we are heading towards profitability". I accept he didn't say when but like Johnsyn has said some of the details of the company have to remain private given the sensitivity .

The support the company has from its major shareholders is immense. This stock is heading in the right direction, 2013 could be a defining year in its history. It has to ramp up turnover and the good dr thankfully acknowledges this fact. Yes I wish that we knew more detail but my trust is in the product and its potential and as long as the major investors back APDN and I believe they will for some time yet I'm quite happy to sit on my shares.

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News